Posterior segment inflammatory outcomes assessed using fluorescein angiography in the STOP-UVEITIS study.
Mohammad Ali SadiqMuhammad HassanRubbia AfridiMuhammad Sohail HalimDiana V DoYasir J SepahQuan Dong Nguyennull nullPublished in: International journal of retina and vitreous (2020)
IV infusions of tocilizumab (both 4 and 8 mg/kg) are effective in improving posterior segment inflammation in eyes with NIU. A semi-quantitative FA scoring system may be used as a reliable outcome measure for assessment of posterior segment inflammation.ClinicalTrials.gov Identifier: NCT01717170.